{
    "nctId": "NCT02755701",
    "officialTitle": "The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With Ascites: A Multi-center, Randomized, Double-blind, Placebo-controlled, Investigator Initiated Clinical Trial",
    "inclusionCriteria": "* Age \u2265 19 and \u2264 70 years;\n* Presence of liver cirrhosis\n* Serum albumin level \u2264 3.5g/dl, ultrasound or CT scan confirmed ascites (\u2265Grade 1)\n* No administration of diuretics and BCAA within the past 1 week\n* Voluntary consent to take part in this trial\n* Must have minimum age of 19 Years\n* Must have maximum age of 70 Years",
    "exclusionCriteria": "* Child-Pugh score \\> 12\n* Having been diagnosed as HCC within the past 5 years\n* Serum creatinine \\> 1.5mg/dl\n* Serum bilirubin \\> 5.0mg/dl\n* Presence of such complications as SBP, or hepatic encephalopathy(West Haven grade \u2265 3)\n* Patients who experienced organ failure by acute exacerbation of liver cirrhosis within the past 1 month\n* Presence of serious cardiac or respiratory disease\n* Contraindicated to either diuretics or BCAA\n* Having commenced anti-viral treatment against hepatitis C, B within the past 1 month\n* Pregnant or lactating women\n* Chronic alcohol taker\n* Woman patients who do not agree to the contraception from baseline to 12 month\n* Unsuitable patients judged by investigator\n* Patients participating in another clinical trial within 1 month"
}